NASDAQ:GHRS • IE000GID8VI0
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GH RESEARCH PLC (GHRS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-06 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2026-03-06 | Needham | Maintains | Buy -> Buy |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-06 | Needham | Maintains | Buy -> Buy |
| 2026-01-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-01-05 | Needham | Reiterate | Buy -> Buy |
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-13 | Needham | Initiate | Buy |
| 2025-06-24 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-09 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | Guggenheim | Initiate | Buy |
| 2025-03-07 | RBC Capital | Initiate | Outperform |
| 2025-02-27 | Stifel | Maintains | Buy -> Buy |
| 2025-02-13 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-01-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-04 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 719.89% | N/A 171.26% | N/A 91.55% | N/A 52.49% | N/A 31.36% | ||||||||
| EBITDA YoY % growth | N/A | N/A | -15.08M | -30.5M -102.25% | -40.907M -34.12% | -49.997M -22.22% | -60.383M -20.77% | N/A -30.07% | N/A -26.30% | N/A 15.73% | N/A -21.05% | N/A 110.38% | N/A 3,721.34% | N/A 197.16% | N/A 43.84% | |
| EBIT YoY % growth | -310K | -450K -45.16% | -15.1M -3,255.56% | -30.55M -102.32% | -41.222M -34.93% | -50.312M -22.05% | -60.718M -20.68% | N/A -69.74% | N/A -31.64% | N/A -19.48% | N/A 32.40% | N/A 163.91% | N/A 425.89% | N/A 102.70% | N/A 47.22% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.43 -37.41% | -0.68 -57.77% | -0.75 -10.29% | -0.80 -6.67% | N/A -110.54% | N/A -9.35% | N/A -9.83% | N/A 17.98% | N/A 114.75% | N/A 1,370.83% | N/A 93.29% | N/A 46.85% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -48.57% | -0.32 -113.18% | -0.38 -64.26% | -0.42 -82.77% | -0.35 -22.85% | -0.40 -24.40% | -0.44 -16.10% | -0.40 5.37% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | -18.258M -44.26% | -20.043M -37.79% | -23.409M -43.46% | -25.194M -53.79% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.488M -53.07% | -21.653M -47.26% | -26.11M -57.62% | -28.424M -70.03% | N/A | N/A | N/A | N/A |
All data in USD
15 analysts have analysed GHRS and the average price target is 40.03 USD. This implies a price increase of 174.78% is expected in the next year compared to the current price of 14.57.
The consensus EPS estimate for the next earnings of GH RESEARCH PLC (GHRS) is -0.28 USD and the consensus revenue estimate is 0 USD.